Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors. | Biofabrication | 2022 | 36108605 | PubTator, text mining | PubMed |
| System Xc -/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. | Front Pharmacol | 2022 | 36105219 | PubTator, text mining | PubMed |
| The potential of plant extracts in cell therapy. | Stem Cell Res Ther | 2022 | 36104798 | PubTator, text mining | PubMed |
| Debilitating hip degeneration in trichothiodystrophy: Association with ERCC2/XPD mutations, osteosclerosis, osteopenia, coxa valga, contractures, and osteonecrosis. | Am J Med Genet A | 2022 | 36103153 | PubTator, text mining | PubMed |
| Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence. | Korean J Radiol | 2022 | 36098343 | PubTator, text mining | PubMed |
| Current updates on generations, approvals, and clinical trials of CAR T-cell therapy. | Hum Vaccin Immunother | 2022 | 36094837 | PubTator, text mining | PubMed |
| The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy. | Front Endocrinol (Lausanne) | 2022 | 36093115 | PubTator, text mining | PubMed |
| High-performance multiplex drug-gated CAR circuits. | Cancer Cell | 2022 | 36084652 | PubTator, text mining | PubMed |
| TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM. | Front Mol Biosci | 2022 | 36081847 | PubTator, text mining | PubMed |
| Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. | Front Immunol | 2022 | 36081506 | PubTator, text mining | PubMed |
| Current Progress of CAR-NK Therapy in Cancer Treatment. | Cancers (Basel) | 2022 | 36077853 | PubTator, text mining | PubMed |
| T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current Developments. | Cancers (Basel) | 2022 | 36077787 | PubTator, text mining | PubMed |
| Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36077730 | PubTator, text mining | PubMed |
| Adverse Renal Effects of Anticancer Immunotherapy: A Review. | Cancers (Basel) | 2022 | 36077623 | PubTator, text mining | PubMed |
| ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes. | Cell Metab | 2022 | 36070682 | PubTator, text mining | PubMed |
| Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review. | Investig Clin Urol | 2022 | 36067994 | PubTator, text mining | PubMed |
| Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma. | Front Oncol | 2022 | 36059638 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans. | Front Immunol | 2022 | 36059490 | PubTator, text mining | PubMed |
| CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies. | Front Immunol | 2022 | 36059451 | PubTator, text mining | PubMed |
| Pooled resequencing of larvae and adults reveals genomic variations associated with Ostreid herpesvirus 1 resistance in the Pacific oyster Crassostrea gigas. | Front Immunol | 2022 | 36059443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=57